These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 2578078)
1. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Goodman ZD; Ishak KG; Langloss JM; Sesterhenn IA; Rabin L Cancer; 1985 Jan; 55(1):124-35. PubMed ID: 2578078 [TBL] [Abstract][Full Text] [Related]
2. Evidence for a hepatocellular lineage in a combined hepatocellular-cholangiocarcinoma of transitional type. Fisher HP; Doppl W; Osborn M; Altmannsberger M Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 56(2):71-6. PubMed ID: 2467436 [TBL] [Abstract][Full Text] [Related]
3. Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. Tickoo SK; Zee SY; Obiekwe S; Xiao H; Koea J; Robiou C; Blumgart LH; Jarnagin W; Ladanyi M; Klimstra DS Am J Surg Pathol; 2002 Aug; 26(8):989-97. PubMed ID: 12170085 [TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma. Haratake J; Hashimoto H Liver; 1995 Feb; 15(1):9-15. PubMed ID: 7539881 [TBL] [Abstract][Full Text] [Related]
6. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression. Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245 [TBL] [Abstract][Full Text] [Related]
7. Expression of ABH and Lewis blood group antigens in combined hepatocellular-cholangiocarcinoma. Possible evidence for the hepatocellular origin of combined hepatocellular-cholangiocarcinoma. Okada Y; Jinno K; Moriwaki S; Morichika S; Torigoe S; Arima T; Nagashima H; Koprowski H Cancer; 1987 Aug; 60(3):345-52. PubMed ID: 3036328 [TBL] [Abstract][Full Text] [Related]
8. The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours. Brumm C; Schulze C; Charels K; Morohoshi T; Klöppel G Histopathology; 1989 May; 14(5):503-13. PubMed ID: 2472345 [TBL] [Abstract][Full Text] [Related]
9. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Ma CK; Zarbo RJ; Frierson HF; Lee MW Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185 [TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. Sasaki M; Nakanuma Y; Ho SB; Kim YS Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202 [TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas. Imai Y; Oda H; Arai M; Shimizu S; Nakatsuru Y; Inoue T; Ishikawa T Jpn J Cancer Res; 1996 Oct; 87(10):1056-62. PubMed ID: 8957064 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of canine primary liver carcinomas: distribution of alpha-fetoprotein, carcinoembryonic antigen, keratins and vimentin. Martín de las Mulas J; Gómez-Villamandos JC; Pérez J; Mozos E; Estrado M; Méndez A Res Vet Sci; 1995 Sep; 59(2):124-7. PubMed ID: 8525100 [TBL] [Abstract][Full Text] [Related]
14. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma. Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309 [TBL] [Abstract][Full Text] [Related]
15. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum. Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123 [TBL] [Abstract][Full Text] [Related]
17. Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor. Teitelbaum DH; Tuttle S; Carey LC; Clausen KP Ann Surg; 1985 Jul; 202(1):36-41. PubMed ID: 2409935 [TBL] [Abstract][Full Text] [Related]
18. A case of diffuse type of combined hepatocellular and cholangiocellular carcinoma initially presented as a localized small nodule. Yoshida T; Okazaki N; Yoshino M; Moriyama N; Hirohashi S Jpn J Cancer Res; 1985 Dec; 76(12):1186-92. PubMed ID: 2419297 [TBL] [Abstract][Full Text] [Related]
19. Histologic markers in primary and metastatic tumors of the liver. Ganjei P; Nadji M; Albores-Saavedra J; Morales AR Cancer; 1988 Nov; 62(9):1994-8. PubMed ID: 2458825 [TBL] [Abstract][Full Text] [Related]
20. Primary liver cell carcinoma. New insight for a more correct approach to its classification. Grigioni WF; D'Errico A; Biagini G; Villanacci V; Mazziotti A; Liotta LA; Garbisa S; Mancini AM Acta Pathol Jpn; 1987 Jun; 37(6):929-40. PubMed ID: 2820184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]